Richard N. Greenberg
Infectious Diseases Division
University of Kentucky School of Medicine
Lexington
KY 40536-0093
USA
Name/email consistency: high
- Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects. Greenberg, R.N., Overton, E.T., Haas, D.W., Frank, I., Goldman, M., von Krempelhuber, A., Virgin, G., Bädeker, N., Vollmar, J., Chaplin, P. J. Infect. Dis. (2013)
- Posaconazole as salvage therapy for zygomycosis. Greenberg, R.N., Mullane, K., van Burik, J.A., Raad, I., Abzug, M.J., Anstead, G., Herbrecht, R., Langston, A., Marr, K.A., Schiller, G., Schuster, M., Wingard, J.R., Gonzalez, C.E., Revankar, S.G., Corcoran, G., Kryscio, R.J., Hare, R. Antimicrob. Agents Chemother. (2006)
- Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial. Greenberg, R.N., Kennedy, J.S., Clanton, D.J., Plummer, E.A., Hague, L., Cruz, J., Ennis, F.A., Blackwelder, W.C., Hopkins, R.J. Lancet (2005)
- Urticaria, exanthems, and other benign dermatologic reactions to smallpox vaccination in adults. Greenberg, R.N., Schosser, R.H., Plummer, E.A., Roberts, S.E., Caldwell, M.A., Hargis, D.L., Rudy, D.W., Evans, M.E., Hopkins, R.J. Clin. Infect. Dis. (2004)